VKH
CADX

Virtu KCG Holdings’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Virtu KCG Holdings’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-13,511
Closed -$85K – 4612
2013
Q3 		$85K Buy
+13,511
New +$85.9K ﹤0.01% 3404

Other funds holding CADX

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Virtu KCG Holdings's CADX Position: Q4 2013 in Review

Virtu KCG Holdings sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q4 2013, closing a stake of 13,511 shares — an estimated $85K sold.

Virtu KCG Holdings first reported a position in CADX in Q3 2013 and held it in 1 quarter. The position peaked at $85K in Q3 2013. 100 funds tracked by Wall St. Rank hold CADX as of Q4 2013.

  • Virtu KCG Holdings reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q4 2013 after selling out during the quarter.
  • Virtu KCG Holdings sold 13,511 CADENCE PHARMACEUTICALS, INC COM STK shares in Q4 2013, an estimated $85K.
  • Virtu KCG Holdings first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q3 2013 and held it in 1 quarter.
  • Virtu KCG Holdings's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $85K in Q3 2013.
  • 100 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q4 2013.

Based on Virtu KCG Holdings's 13F filing for Q4 2013, filed 13 Feb 2014.